| (210) | Number of the EPO application | 16728462 |
| (220) | Filing date of the EPO application | 2016.05.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 27/2019, 2019.07.03 |
| (110) | EPO patent number | 3297611 |
| (21) | Number of the application | e 2018 0292 |
| (71) | Name(s) of applicant(s), code of the country | Agenebio, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GALLAGHER Michela, US;
ROSENZWEIG-LIPSON Sharon, US;
MELSOPP Elsie, US;
JAMES Jack Lawrence, US;
PAYIE Kenneth Garry, US; |
| (73) | Name(s) of owner(s), code of the country | AGENEBIO Inc., US; |
| (54) | Title of the invention | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61K 31/4015 (2006.01.01); A61K 9/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.05.31 |
| (30) | Priority | 201562165812 P, 2015.05.22, US |
| (86) | International application | PCT/US2016/033567, 2016.05.20 |
| (87) | International publication | WO 2016/191288, 2016.12.01 |